Stock RGLS REGULUS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Real-time Estimate Cboe BZX
Other stock markets
 01:01:34 2024-05-09 pm EDT 		5-day change 1st Jan Change
2.255 USD -0.66% Intraday chart for Regulus Therapeutics Inc. -15.99% +76.56%
May. 06 Regulus Therapeutics Advances to Cohort 4 of Phase 1B Multiple-Ascending Dose Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease CI
Mar. 21 Regulus Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Revisions Regulus Therapeutics Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW